Quick Answer
TherapeuticsMD, Inc. reported Long-Term Debt of $0.00 for fiscal year 2021.
TherapeuticsMD, Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2021 | $0.00 | -100.0% |
| 2020 | $237.70M | +22.1% |
| 2019 | $194.63M | +165.2% |
| 2018 | $73.38M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2021 | $171.74M | -27.6% | -2.0% |
| June 30, 2021 | $175.26M | -28.1% | -2.1% |
| March 31, 2021 | $178.97M | -26.5% | -24.7% |
| December 31, 2020 | $237.70M | +22.1% | +0.3% |
| September 30, 2020 | $237.05M | +22.0% | -2.8% |
| June 30, 2020 | $243.80M | +25.6% | +0.2% |
| March 31, 2020 | $243.43M | +231.2% | +25.1% |
| December 31, 2019 | $194.63M | +165.2% | +0.1% |
- TherapeuticsMD, Inc. showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- Over the 2018–2021 period, TherapeuticsMD, Inc.’s long-term debt has declined by 100.0% (from $73.38 million to $0.00).
- The most recent figure is from TherapeuticsMD, Inc.’s fiscal year 2021 report (Form 10-K), filed with the SEC on March 23, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: